Cell-mediated immunity of natural killer and CD8 cells

Last updated: November 01, 2022

Cell-mediated immunity of natural killer and CD8 cells

Critical Care - Nursing

Critical Care - Nursing

Shock: Clinical
Burns: Clinical
Asthma: Clinical
Seizures: Clinical
Skin cancer: Clinical
Neck trauma: Clinical
Stroke: Clinical
Pancreatitis: Clinical
Heart failure: Clinical
Hypertension: Clinical
Brain herniation
Concussion and traumatic brain injury
Traumatic brain injury: Pathology review
Traumatic brain injury: Clinical
Intracerebral hemorrhage
Bundle branch block
ECG basics
ECG rate and rhythm
ECG axis
ECG cardiac infarction and ischemia
Wolff-Parkinson-White syndrome
Atrioventricular block
Atrioventricular nodal reentrant tachycardia (AVNRT)
Atrial flutter
Atrial fibrillation
ECG normal sinus rhythm
Ventricular arrhythmias: Pathology review
Supraventricular arrhythmias: Pathology review
Ventricular fibrillation
Myocarditis
Class II antiarrhythmics: Beta blockers
Class IV antiarrhythmics: Calcium channel blockers and others
Tricyclic antidepressants
Dilated cardiomyopathy
Class III antiarrhythmics: Potassium channel blockers
Positive inotropic medications
Class I antiarrhythmics: Sodium channel blockers
Coronary artery disease: Pathology review
Seizures: Pathology review
Endocarditis: Pathology review
Shock: Pathology review
Hypertension: Pathology review
Heart failure: Pathology review
Cardiomyopathies: Pathology review
Cirrhosis: Pathology review
Pancreatitis: Pathology review
Headaches: Pathology review
Ventilation-perfusion ratios and V/Q mismatch
Clinical Skills: Mechanical ventilation - conventional ventilators
Clinical Skills: High-frequency oscillatory ventilation (HFOV)
Respiratory alkalosis
Respiratory acidosis
Acute respiratory distress syndrome: Clinical
Pulmonary embolism
Acute respiratory distress syndrome
Advanced cardiac life support (ACLS): Clinical
Deep vein thrombosis and pulmonary embolism: Pathology review
Obstructive lung diseases: Pathology review
Respiratory distress syndrome: Pathology review
Blood products and transfusion: Clinical
Ventilation
Anatomic and physiologic dead space
B- and T-cell memory
Zones of pulmonary blood flow
Action potentials in pacemaker cells
Reading a chest X-ray
Renal failure: Pathology review
Regulation of renal blood flow
Heart failure
Toxidromes: Clinical
Child abuse: Clinical
Carbon monoxide poisoning: Nursing process (ADPIE)
Chest trauma: Clinical
Angina pectoris
Coronary artery disease: Clinical
Antiplatelet medications
cGMP mediated smooth muscle vasodilators
Sympathomimetics: Direct agonists
Compliance of lungs and chest wall
Combined pressure-volume curves for the lung and chest wall
Stable angina
Ludwig angina
Unstable angina
Normal heart sounds
Abnormal heart sounds
Rheumatic heart disease
Heart blocks: Pathology review
Hypoplastic left heart syndrome
Cardiac conduction system
Acyanotic congenital heart defects: Pathology review
Cyanotic congenital heart defects: Pathology review
Post-COVID syndrome: Heart, lungs and clotting
Myocardial infarction
Congenital heart defects: Clinical
MHC class I and MHC class II molecules
T-cell activation
Type III hypersensitivity
Antiphospholipid syndrome
B-cell activation, differentiation, and contraction
Type IV hypersensitivity
Graft-versus-host disease
Antibody classes
Type II hypersensitivity
Integrase and entry inhibitors
Small bowel ischemia and infarction
ACE inhibitors, ARBs and direct renin inhibitors
Cell-mediated immunity of CD4 cells
Cell-mediated immunity of natural killer and CD8 cells
Anaphylaxis
Shock
Hemophilia
Non-steroidal anti-inflammatory drugs
Transplant rejection
Stroke volume, ejection fraction, and cardiac output
Delirium
Dementia and delirium: Clinical
Amnesia, dissociative disorders and delirium: Pathology review
Substance misuse and addiction: Clinical
Typical antipsychotics
Metabolic and respiratory acidosis: Clinical
Dementia with Lewy bodies
Vascular dementia
Abnormal uterine bleeding: Clinical
Bleeding disorders: Clinical
Headaches: Clinical
Post-traumatic stress disorder
Trauma- and stressor-related disorders: Clinical
Clinical Skills: Pulse oximetry
Clinical Skills: BiPAP and CPAP
Anemia: Clinical
Aortic dissections and aneurysms: Pathology review
Aortic aneurysms and dissections: Clinical
Aortic dissection
Cardiac tamponade
Pericardial disease: Pathology review
Coarctation of the aorta
Hypertension
Pneumothorax
Pneumothorax: Clinical
Pleural effusion, pneumothorax, hemothorax and atelectasis: Pathology review
General anesthetics
Emphysema
Pleural effusion: Clinical
Abdominal trauma: Clinical
Glycolysis
Carbohydrates and sugars
Oxygen-hemoglobin dissociation curve
Cellular structure and function
Fatty acid synthesis
Ketone body metabolism
Metabolic acidosis
Disorders of consciousness: Clinical
Hyperkalemia: Clinical
Acid-base disturbances: Pathology review
Plasma anion gap
Diabetes mellitus
Diabetes mellitus: Clinical
Diabetes mellitus: Pathology review
Electrolyte disturbances: Pathology review
Fatty acid oxidation
Alveolar gas equation
Gas exchange in the lungs, blood and tissues
Cardiac muscle histology
Neuromuscular blockers
Long QT syndrome and Torsade de pointes
Opioid agonists, mixed agonist-antagonists and partial agonists
Anticonvulsants and anxiolytics: Benzodiazepines
Nonbenzodiazepine anticonvulsants
Bipolar and related disorders
Serotonin and norepinephrine reuptake inhibitors
Seizures and epilepsy
Hypertensive emergency
Hypertensive disorders of pregnancy: Clinical
Adrenergic antagonists: Alpha blockers
Adrenergic antagonists: Beta blockers
Cardiac work
Cardiac cycle
Cardiac afterload
Cardiac contractility
ECG cardiac hypertrophy and enlargement
Cardiac conduction velocity
Imaging features of COVID-19 (LifeBridge Health)
Altering cardiac and vascular function curves
Action potentials in myocytes
Resting membrane potential
Valvular heart disease: Clinical
Anatomy of the heart
Valvular heart disease: Pathology review
Premature ventricular contraction
Brugada syndrome
Premature atrial contraction
Sleep apnea
Cardiomyopathies: Clinical
Metabolic and respiratory alkalosis: Clinical
Neonatal respiratory distress syndrome
Bronchodilators: Leukotriene antagonists and methylxanthines
Hypokalemia
Hyperkalemia
Newborn management: Clinical
Carbonic anhydrase inhibitors
Regulation of pulmonary blood flow
Baroreceptors
Cranial nerves
Renin-angiotensin-aldosterone system
Anticonvulsants and anxiolytics: Barbiturates
Chronic bronchitis
Bronchiectasis
Brown-Sequard Syndrome
Bacterial epiglottitis
Ectopic pregnancy
Complications during pregnancy: Pathology review
Miscarriage
B-cell development
Placental abruption
Abnormal labor: Clinical
Ischemia
Ascending and descending spinal tracts
Spinal cord disorders: Pathology review
Pyramidal and extrapyramidal tracts
Acute kidney injury: Clinical
Free radicals and cellular injury
DNA damage and repair
Metabolic alkalosis
The role of the kidney in acid-base balance
Psychomotor stimulants
Carbon dioxide transport in blood
Acid-base map and compensatory mechanisms
Pulmonary shunts
Cardiovascular system anatomy and physiology
Pulmonary edema
Sleep disorders: Clinical

Transcript

Watch video only

The key cells of the adaptive immune response are the lymphocytes - the B and T cells.

And there are two types of T cells.

Helper T cells which express CD4 on their surface, and cytotoxic T cells which express CD8 on their surface.

Helper T cells primarily support other immune cells, whereas cytotoxic T cells kill cells that are infected with a pathogen or are cancerous.

Cytotoxic T cells, along with natural killer cells, are part of cell mediated immunity.

Cell mediated immunity refers to the part of the immune response that’s based on cellular interactions, and cannot be transferred through serum from one person to another.

That makes sense since both natural killer and cytotoxic T cells need to interact directly with a target cell in order to destroy it.

Now, when a T cell is initially formed it’s considered naive.

Later when that T cell encounters an antigen in the lymph node- it gets activated or primed - and turns into an effector T cell.

This process of priming requires two signals.

The first signal is the antigen itself, which is usually presented on an MHC molecule on the surface of an antigen presenting cell like a macrophage or dendritic cell.

Cytotoxic T cells respond to intracellular antigens - like viruses, intracellular bacteria, and tumor antigens.

The naive cytotoxic T cell needs a high level of stimulation to become activated and it relies on a process called cross-presentation to reach that level.

In cross-presentation macrophages or dendritic cells take up the antigen and then present it to the cytotoxic T cell.

These antigens typically come from extracellular pathogens or from tumor cells or virally infected cells.

The first signal is that the antigen has to bind perfectly to the T cell receptor or TCR.

The second signal is called costimulation - and it’s when a ligand called CD28 on the surface of a T cell binds to a ligand called B7 on the antigen presenting cell.

This region, which includes the T cell receptor which binds to the MHC-Antigen, and CD8 and CD28 which bind with B7, is called the immune synapse.

Once the T cell receives both of these signals, a number of changes occur within the cell that transforms the naive T cell into a cytotoxic T cell.

The activated T helper cell also begins making lots of cytokine IL-2, and upregulates its IL-2 alpha receptor.

The IL-2 receptor has three protein components - alpha, beta, and gamma.

A naive T cell only expresses the beta and gamma components of the IL-2 receptor, but these have low affinity for IL-2, in contrast to the alpha component of the IL-2 receptor which has a high affinity for IL-2.

Using just the beta and gamma components is like trying to eat an apple with only your lips and tongue.

And upregulating the alpha component is like using your teeth to take a big bite out of the juicy apple - much more effective and satisfying!

As a result active T cells make more IL-2 and then bind to the IL-2 that they make with their IL-2 receptors - a form of autocrine stimulation - a cell stimulating itself.

In response to the IL-2, the activated T cell starts to rapidly undergo cell division - a process called clonal expansion.

The cytotoxic T cell is now a lean, mean, killing machine that’s ready to attack.

This activated cytotoxic T cell only needs to see its antigen in the context of MHC I in order to kill the cell.

In other words, it no longer needs that costimulatory signal from CD28.

And the way that cytotoxic T cells find potential targets is by going cell-to-cell binding non-specifically.

They use adhesion molecules like LFA-1 on their surface to bind to molecules like ICAM which is found on the surface of most cells.

After loosely binding in this way, it tries to bind to that cell’s MHC I molecule.

If the cytotoxic T cell cannot bind because the correct antigen isn’t present, then the cytotoxic T cell disengages and moves on to the next cell.

Key Takeaways

https://osmosis.org/learn/Cell-mediatedimmunityofnaturalkillerandCD8_cells

Natural killer cells are innate lymphocytes that play a critical role in the early response to viral infection and cancer. They detect virus-infected cells and eliminate them before they can spread the infection. CD8 cells are cytotoxic T lymphocytes that recognize and kill infected or mutated cells. CD8 cells also secrete cytokines that stimulate the immune response. Both natural killer cells and CD8 cells are essential in protecting against cancer and infections.